Harmony Partners — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Nectar Life Sciences, Inc.Dec 2022SEC filingmedium confidence
New York, US
Board seatMark Lotke· per SEC Form D · $24.3M raise · filed Dec 2022
Co-investorsObvious Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.